TELL ME MORE
ABOUT THIS CLINICAL TRIAL for INFANT FORMULA
This is an Active Comparitor Infant Formula Study in Babies of a Modified Formula to a Marketed Formula and/or Breat Milk

Clinical Trial for an Infant Formula Study
Study Location(s): Owensboro and Bowling Green Kentucky; Evansville Indiana
Inclusion Criteria: Healthy Full Term Babies (37weeks) ≤ 14 days of age
Infant formula is a manufactured food designed and marketed for feeding to babies and infants under 12 months of age. The U.S. Federal Food, Drug, and Cosmetic Act (FFDCA) defines infant formula as “a food which purports to be or is represented for special dietary use solely as a food for infants by reason of its simulation of human milk or its suitability as a complete or partial substitute for human milk”. This is an active comparitor infant forumla study in babies between a modified formulation and a currently marketed forulation and/or breast milk fed infants. Click here for FDA Infant Formula Q&As.
There is no cost to participate. Volunteers receive free investigational formula and follow-up care. No insurance needed. Time and travel reimburrsement up to $200 may be available. Formula and diapers provided at no cost.
View More Studies
Condition | Location | Status | Age Range | Sex | Max Compensation | |
---|---|---|---|---|---|---|
ACNE Trifarotene Cream used with and 0ral antibiotic to treat severe acne vulgaris | Evansville | Recruiting | 12+ | $600 | Request Info | |
ADHD A Long-term active comparitor and dose optimization study to evaluate safety and efficacy of a non-stimulat medication | Owensboro | Recruiting | 6 - 17 | $1150 | Request Info | |
ADHD A randomized, double-blind, multicenter, placebo-controlled study to evaluatate efficacy and safety of an investigational medicine in preschool-age children | Bowling Green Evansville Owensboro | Coming Soon | 4 - 5 | $400 | Request Info | |
ALOPECIA AREATA Safety and efficacy, placebo-controlled with open-label extension study in patients with severe alopecia areata | Owensboro | Recruiting | 18 - 65 | $500 | Request Info | |
ASTHMA Safety and Efficacy Study of a Fixed Dose Combination (FDC) in Subjects With Asthma | Evansville | Recruiting | 5 - 17 | $800 | Request Info | |
COMMON WARTS Efficacy, Safety and Tolerability Study in Children and Adults with Common Warts | Evansville | Coming Soon | 2+ | $350 | Request Info | |
COVID-19 Safety and Eficacy Study of a Monoclonal Antibody Therapy for Patients with Mild to Moderate COVID-19 | Evansville Owensboro | Recruiting | 18+ | $3000 | Request Info | |
DIABETES (T2DM) Active Comparator Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors | BowlingGreen Owensboro | Recruiting | 40 + | $600/year (long-term study could last up to 5 years) | Request Info | |
ECZEMA An open-label expanded access study in adult and adolescent patients age 12+ with moderate-to-severe Atopic Dermatitis (Eczema) | Evansville | Coming Soon | 12+ | $50 per visit | Request Info | |
IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Recruiting | 18 - 80 | $3200 | Request Info | |
IBD - ULCERATIVE COLITIS A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Ulcerative Colitis | Evansville | Recruiting | 18 - 80 | $1100 | Request Info | |
IBS- CONSTIPATION An efficacy and safety, placebo-controlled study for patients with constipation due to irritable bowel syndrome | BowlingGreen Evansville | Paused | 6 - 17 | $350 | Request Info | |
INFANT FORMULA Comparison Study | BowlingGreen Evansville Owensboro | Recruiting | Newborns | Variable up to $1700, + formula and diapers | Request Info | |
INFANT VACCINE Comparison Study between two meningococcal vaccines | Evansville | Recruiting | Newborns | Variable up to $400 | Request Info | |
INFANT VACCINE Comparison Study between two pneumococcal vaccines | Bowling Green | Coming Soon | Newborns | Variable up to $400 | Request Info | |
LUPUS ERYTHEMATOSUS A Safety, efficacy and dose ranging comparison study for patients with moderate to severely active Systemic Lupus Erythematosus | Evansville | Recruiting | 18 - 65 | $750 | Request Info | |
MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Recruiting | 6 - 17 | $200/$350 | Request Info | |
MOLLUSCUM (Water Warts) An efficacy and safety, placebo-controlled study for patients with molluscum contagiosum | BowlingGreen Owensboro Evansville | Recruiting | 6 MO+ (children and adults) | $645 | Request Info | |
PRURITUS (CHRONIC ITCH) An efficacy and safety study for the treatment of chronic itch in adult subjects with atopic dermatitis | Owensboro | Coming Soon | 18 - 75 | $600 | Request Info | |
RHEUMATOID ARTHRITIS (RA) This is a comparison study to evaluate an investigational medicine for Rheumatoid Arthritis in adults with moderately or severely active disease and who have had inadequate response to conventional synthetic or biologic Disease Modifying Anti-rheumatic Drugs (DMARDs). | Evansville | Coming Soon | 18+ | Up to $1750 | Request Info | |